Ocumension Therapeutics IPO: Trading Debut
Ocumension Therapeutics (1477 HK) is a China-based ophthalmic pharmaceutical company dedicated to identifying, developing and commercializing...
405 Views
Ocumension (欧康维视) IPO Trading: Share Could Double Thanks to Record Demand
Ocumension raised HKD 1,424 million (USD 183 m) from its global offering and will list on the Hong Kong Stock Exchange tomorrow. In our previous...
392 Views
ECM Weekly (4 July 2020) - Smoore, Ocumension, Zhenro Services, Archosaur Games
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. It...
363 Views
Ocumension Therapeutics IPO: Valuation Insights
Ocumension Therapeutics (1477 HK) is a China-based ophthalmic pharmaceutical company dedicated to identifying, developing and commercializing...
661 Views
Ocumension (欧康维视) IPO: Hot Deal, Small Float
Ocumension Therapeutics, a leading ophthalmic pharmaceutical platform company with a focus on first-in-class or best-in-class ophthalmic...
413 Views